Sundeep Dugar

2.5k citations

70 papers · 1.9k indexed · h-index 24

Molecular Biology top 10%
Organic Chemistry top 5%
Oncology top 10%
Pulmonary and Respiratory Medicine top 10%
Physiology top 10%

Co-authors: Sarvajit Chakravarty Andrew A. Protter Rebecca Miller Linda S. Higgins George F. Schreiner Ann M. Kapoun Alison Murphy John W. Clader
Topics: Melanoma and MAPK Pathways (13 papers)Synthesis of β-Lactam Compounds (9 papers)Synthesis and biological activity (8 papers)
Cited by: Organic Chemistry Molecular Biology Oncology
Journals: The EMBO Journal Blood American Journal of Respiratory and Critical Care Medicine
Partner nations: United States Mexico New Zealand

In The Last Decade

Sundeep Dugar

67 papers receiving 1.8k citations

Peers

Countries citing papers authored by Sundeep Dugar

Since Specialization

Citations

This map shows the geographic impact of Sundeep Dugar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sundeep Dugar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sundeep Dugar more than expected).

Fields of papers citing papers by Sundeep Dugar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sundeep Dugar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sundeep Dugar. The network helps show where Sundeep Dugar may publish in the future.

Co-authorship network of co-authors of Sundeep Dugar

This figure shows the co-authorship network connecting the top 25 collaborators of Sundeep Dugar. A scholar is included among the top collaborators of Sundeep Dugar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sundeep Dugar. Sundeep Dugar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SPR965, a Dual PI3K/mTOR Inhibitor, as a Targeted Therapy in Ovarian Cancer 2021 ·Frontiers in Oncology ·(unknown),(unknown),Leo Li‐Ying Chan,Yajie Yin,Wenchuan Sun,Ziwei Fang,Sundeep Dugar,Chunxiao Zhou,Victoria Bae‐Jump	5
2	11-β-hydroxysterols as possible endogenous stimulators of mitochondrial biogenesis as inferred from epicatechin molecular mimicry 2019 ·Pharmacological Research ·Sundeep Dugar,Francisco Villarreal,(unknown),Dinesh Mahajan,Israel Ramírez‐Sánchez,Aldo Moreno‐Ulloa,Guillermo Ceballos,George F. Schreiner	8
3	A randomized, placebo-controlled, double-blind study on the effects of (−)-epicatechin on the triglyceride/HDLc ratio and cardiometabolic profile of subjects with hypertriglyceridemia: Unique in vitro effects 2016 ·International Journal of Cardiology ·Gabriela Gutiérrez-Salmeán,Eduardo Meaney,Miguel A. Lanaspa,Christina Cicerchi,Richard J. Johnson,Sundeep Dugar,Pam R. Taub,Israel Ramírez‐Sánchez,Francisco Villarreal,George F. Schreiner,Guillermo Ceballos	51
4	Design and synthesis of piperazine-indole p38α MAP kinase inhibitors with improved pharmacokinetic profiles 2010 ·Bioorganic & Medicinal Chemistry Letters ·Xuefei Tan,Richland Tester,Gregory R. Luedtke,Sarvajit Chakravarty,Babu Mavunkel,John Perumattam,Qing Lu,(unknown),Joon Jung,Jie Hu,Albert Liclican,Ramona G. Almirez,(unknown),Vinh Tran,Maureen Laney,Daniel E. Levy,Sundeep Dugar	12
5	Amide-based inhibitors of p38α MAP kinase. Part 2: Design, synthesis and SAR of potent N-pyrimidyl amides 2010 ·Bioorganic & Medicinal Chemistry Letters ·Richland Tester,Xuefei Tan,Gregory R. Luedtke,(unknown),(unknown),(unknown),Joon Jung,Sundeep Dugar,Albert Liclican,(unknown),Daniel E. Levy,Steven Do	2
6	Amide-based inhibitors of p38α MAP kinase. Part 1: Discovery of novel N-pyridyl amide lead molecules 2010 ·Bioorganic & Medicinal Chemistry Letters ·Gregory R. Luedtke,(unknown),Xuefei Tan,Richland Tester,(unknown),Yongjin Xu,Sundeep Dugar,Daniel E. Levy,Joon Jung	10
7	Piperidine-based heterocyclic oxalyl amides as potent p38α MAP kinase inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Babu Mavunkel,John Perumattam,Xuefei Tan,Gregory R. Luedtke,Qing Lu,(unknown),Darin Kizer,Sundeep Dugar,Sarvajit Chakravarty,Yongjin Xu,Joon Jung,Albert Liclican,Daniel E. Levy,(unknown)	21
8	Aryl–indolyl maleimides as inhibitors of CaMKIIδ. Part 1: SAR of the aryl region 2008 ·Bioorganic & Medicinal Chemistry Letters ·Daniel E. Levy,(unknown),Qing Lu,Zheng Chen,John Perumattam,Yongjin Xu,Albert Liclican,Jeffrey N. Higaki,(unknown),Maureen Laney,Babu Mavunkel,Sundeep Dugar	14
9	Aryl-indolyl maleimides as inhibitors of CaMKIIδ. Part 2: SAR of the amine tether 2008 ·Bioorganic & Medicinal Chemistry Letters ·Daniel E. Levy,(unknown),Qing Lu,Zheng Chen,John Perumattam,Yongjin Xu,Jeffrey N. Higaki,(unknown),Albert Liclican,Maureen Laney,Babu Mavunkel,Sundeep Dugar	9
10	Pyrimidine-based inhibitors of CaMKIIδ 2008 ·Bioorganic & Medicinal Chemistry Letters ·Babu Mavunkel,Yongjin Xu,Bindu Goyal,(unknown),Qing Lu,Zheng Chen,(unknown),Jeffrey N. Higaki,Indrani Chakraborty,Albert Liclican,Steve Sideris,Maureen Laney,Ulrike Delling,Rosanne Catalano,Linda S. Higgins,Hui Wang,Jing Wang,Ying Feng,Sundeep Dugar,Daniel E. Levy	13
11	p38α-Selective Mitogen-Activated Protein Kinase Inhibitor SD-282 Reduces Inflammation in a Subchronic Model of Tobacco Smoke-Induced Airway Inflammation 2007 ·Journal of Pharmacology and Experimental Therapeutics ·Satyanarayana Medicherla,(unknown),(unknown),Paul Woodman,(unknown),Ann M. Kapoun,Sarvajit Chakravarty,Sundeep Dugar,Andrew A. Protter,Linda S. Higgins	75
12	Inhibition of Growth and Metastasis of Mouse Mammary Carcinoma by Selective Inhibitor of Transforming Growth Factor-β Type I Receptor Kinase In vivo 2006 ·Clinical Cancer Research ·Rongrong Ge,(unknown),Partha Ray,Edmund C. Lattime,Susan R. Rittling,Satya Medicherla,Andy Protter,Alison Murphy,(unknown),Sundeep Dugar,George F. Schreiner,Nicola Barnard,Michael Reiß	123
13	A Selective p38α Mitogen-Activated Protein Kinase Inhibitor Reverses Cartilage and Bone Destruction in Mice with Collagen-Induced Arthritis 2006 ·Journal of Pharmacology and Experimental Therapeutics ·Satyanarayana Medicherla,Ying Jing,Ruban Mangadu,Yebin Jiang,Jenny Zhao,Ramona G. Almirez,Irene Kerr,Elizabeth G. Stebbins,Gilbert O’Young,Ann M. Kapoun,Gregory R. Luedtke,Sarvajit Chakravarty,Sundeep Dugar,Harry K. Genant,Andrew A. Protter	65
14	Selective inhibition of p38α MAPK improves cardiac function and reduces myocardial apoptosis in rat model of myocardial injury 2006 ·American Journal of Physiology-Heart and Circulatory Physiology ·Zhihe Li,Ying Jing,Irene Kerr,Sarvajit Chakravarty,Sundeep Dugar,George F. Schreiner,Andrew A. Protter	60
15	Preventive and Therapeutic Potential of p38α-Selective Mitogen-Activated Protein Kinase Inhibitor in Nonobese Diabetic Mice with Type 1 Diabetes 2006 ·Journal of Pharmacology and Experimental Therapeutics ·Satyanarayana Medicherla,Andrew A. Protter,Ying Jing,Ruban Mangadu,Ramona G. Almirez,Bruce Koppelman,Irene Kerr,Tony Navas,(unknown),(unknown),Yuwang Liu,(unknown),John Perumattam,Babu Mavunkel,Sundeep Dugar,George F. Schreiner	13
16	A p38α Selective Mitogen-Activated Protein Kinase Inhibitor Prevents Periodontal Bone Loss 2006 ·Journal of Pharmacology and Experimental Therapeutics ·Keith L. Kirkwood,Fei Li,(unknown),(unknown),(unknown),Jaclynn M. Kreider,Nisha J. D’Silva,Sarvajit Chakravarty,Sundeep Dugar,Linda S. Higgins,Andrew A. Protter,Satyanarayana Medicherla	56
17	Progressive Transforming Growth Factor β1–induced Lung Fibrosis Is Blocked by an Orally Active ALK5 Kinase Inhibitor 2004 ·American Journal of Respiratory and Critical Care Medicine ·Philippe Bonniaud,Peter J. Margetts,Martin Kolb,(unknown),Ann M. Kapoun,Debby Damm,Alison Murphy,Sarvajit Chakravarty,Sundeep Dugar,Linda S. Higgins,Andrew A. Protter,Jack Gauldie	210
18	Selective inhibitors of type I receptor kinase block cellular transforming growth factor-β signaling 2004 ·Biochemical Pharmacology ·Rongrong Ge,(unknown),(unknown),Kim A. Reiss,David Liu,Linda S. Higgins,Alison Joly,Sundeep Dugar,(unknown),Margaret Henson,Glenn McEnroe,George F. Schreiner,Michael Reiß	28
19	Diphenylsulfone muscarinic antagonists: piperidine derivatives with high m2 selectivity and improved potency 2000 ·Bioorganic & Medicinal Chemistry Letters ·William Billard,Herbert Binch,(unknown),(unknown),Gordon Crosby,Ruth A. Duffy,Sundeep Dugar,Jean E. Lachowicz,(unknown),(unknown),Vilma Ruperto,Lisa A. Taylor,John W. Clader	13
20	Substituted (1,2-Diarylethyl)amide Acyl-CoA:Cholesterol Acyltransferase Inhibitors: Effect of Polar Groups on in Vitro and in Vivo Activity 1995 ·Journal of Medicinal Chemistry ·John W. Clader,Joel G. Berger,Robert E. Burrier,Harry R. Davis,Martin S. Domalski,Sundeep Dugar,Timothy P. Kogan,Brian Salisbury,Wayne Vaccaro	22

About Sundeep Dugar

Sundeep Dugar is a scholar working on Organic Chemistry, Toxicology and Molecular Biology, having authored 70 papers that have together received 1.9k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (13 papers), Synthesis of β-Lactam Compounds (9 papers) and Synthesis and biological activity (8 papers). The work is most often cited by research in Organic Chemistry (542 citations), Molecular Biology (875 citations) and Oncology (330 citations). Sundeep Dugar has collaborated with scholars based in United States, Mexico and New Zealand. Frequent co-authors include Sarvajit Chakravarty, Andrew A. Protter, Rebecca Miller, Linda S. Higgins, George F. Schreiner, Ann M. Kapoun, Alison Murphy, John W. Clader, Satyanarayana Medicherla and Michael Reiß. Their work appears in journals such as The EMBO Journal, Blood and American Journal of Respiratory and Critical Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact